Given that hepcidin is cleared by the kidney, its serum levels are increased in renal failure patients with anemia (13, 14) and associated with iron-restricted erythropoiesis and resistance to recombinant human erythropoietin treatment (14). This evidence concerns the gene EPO and anemia.